John Markels
Director/Board Member chez SANGAMO THERAPEUTICS, INC.
Fortune : 21 764 $ au 31/03/2024
Profil
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. He is also a Director at Arcturus Therapeutics, Inc., Arcturus Therapeutics Ltd., and Arcturus Therapeutics Holdings, Inc. Previously, he served as the President-Global Vaccines at Merck & Co., Inc. Dr. Markels holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2024 | 32 484 ( 0,02% ) | 21 764 $ | 31/03/2024 | |
| 15/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de John Markels
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 11/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 08/12/2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Anciens postes connus de John Markels
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/03/2022 |
Formation de John Markels
| University of California, Berkeley | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
